See more : Silicon Touch Technology Inc. (3288.TWO) Income Statement Analysis – Financial Results
Complete financial analysis of Sunil Healthcare Limited (SUNLOC.BO) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Sunil Healthcare Limited, a leading company in the Medical – Pharmaceuticals industry within the Healthcare sector.
- NorthWest Healthcare Properties Real Estate Investment Trust (NWH-UN.TO) Income Statement Analysis – Financial Results
- Tantalus Systems Holding Inc. (TNTLF) Income Statement Analysis – Financial Results
- TOYAM SPORTS LIMITED (TOYAMSL.BO) Income Statement Analysis – Financial Results
- inTerra Resources Corp (ITRX) Income Statement Analysis – Financial Results
- Ganesh Films India Limited (GFIL.BO) Income Statement Analysis – Financial Results
Sunil Healthcare Limited (SUNLOC.BO)
Industry: Medical - Pharmaceuticals
Sector: Healthcare
About Sunil Healthcare Limited
Sunil Healthcare Ltd. engages in the manufacture of empty hard gelatin capsule shells. Its products include hard gelatin capsules, vegetable capsules, and pullulan capsules. The company was founded by S. N. Khaitan on February 5, 1973 and is headquartered in New Delhi, India.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 901.59M | 1.10B | 1.19B | 903.28M | 695.41M | 802.34M | 895.00M | 1.01B | 809.13M | 721.01M | 608.87M | 461.33M | 428.36M |
| Cost of Revenue | 500.96M | 510.99M | 531.06M | 465.36M | 316.66M | 300.20M | 373.75M | 528.38M | 366.57M | 331.74M | 227.71M | 157.37M | 166.26M |
| Gross Profit | 400.63M | 593.57M | 660.52M | 437.92M | 378.75M | 502.15M | 521.25M | 480.27M | 442.56M | 389.27M | 381.16M | 303.96M | 262.09M |
| Gross Profit Ratio | 44.44% | 53.74% | 55.43% | 48.48% | 54.46% | 62.59% | 58.24% | 47.62% | 54.70% | 53.99% | 62.60% | 65.89% | 61.19% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 16.63M | 24.07M | 23.95M | 20.01M | 15.56M | 19.83M | 20.23M | 11.85M | 7.12M | 8.88M | 6.74M | 6.41M | 5.26M |
| Selling & Marketing | 26.02M | 31.03M | 30.50M | 25.93M | 21.65M | 19.74M | 21.22M | 22.77M | 23.10M | 14.64M | 15.97M | 11.93M | 13.52M |
| SG&A | 42.64M | 55.10M | 54.44M | 45.94M | 37.21M | 39.57M | 41.46M | 34.62M | 30.22M | 23.52M | 22.72M | 18.34M | 18.78M |
| Other Expenses | 357.99M | 2.81M | 51.00K | 280.00K | 20.73M | 6.39M | 6.10M | 7.55M | 5.31M | 1.62M | 772.00K | 849.00K | 2.72M |
| Operating Expenses | 400.63M | 474.95M | 495.89M | 391.28M | 478.56M | 446.27M | 418.05M | 369.40M | 329.45M | 304.15M | 293.74M | 267.77M | 212.67M |
| Cost & Expenses | 901.92M | 985.94M | 1.03B | 856.64M | 795.22M | 746.46M | 791.79M | 897.78M | 696.03M | 635.90M | 521.45M | 425.14M | 378.93M |
| Interest Income | 2.55M | 2.11M | 2.16M | 3.18M | 3.67M | 1.40M | 2.45M | 1.71M | 1.38M | 1.38M | 1.04M | 873.00K | 1.40M |
| Interest Expense | 57.78M | 33.32M | 25.54M | 44.97M | 61.74M | 57.27M | 50.25M | 40.45M | 35.84M | 25.10M | 22.33M | 21.79M | 16.75M |
| Depreciation & Amortization | 60.86M | 70.12M | 63.07M | 61.14M | 61.28M | 57.40M | 47.83M | 43.34M | 38.20M | 40.01M | 40.94M | 38.21M | 32.11M |
| EBITDA | 93.08M | 206.63M | 190.61M | 108.69M | 100.83M | 115.13M | 164.73M | 164.05M | 154.34M | 130.09M | 123.99M | 86.19M | 84.02M |
| EBITDA Ratio | 10.32% | 18.27% | 19.10% | 10.85% | -2.02% | 13.11% | 18.02% | 16.25% | 19.27% | 17.99% | 19.82% | 15.77% | 19.12% |
| Operating Income | -19.98M | 91.22M | 111.86M | 18.11M | -108.50M | 50.15M | 95.48M | 86.12M | 80.30M | 61.99M | 51.20M | 21.96M | 32.81M |
| Operating Income Ratio | -2.22% | 8.26% | 9.39% | 2.00% | -15.60% | 6.25% | 10.67% | 8.54% | 9.92% | 8.60% | 8.41% | 4.76% | 7.66% |
| Total Other Income/Expenses | -5.57M | 3.29M | -71.98M | -52.17M | 78.50M | -58.22M | -40.10M | -7.24M | 1.00K | -441.00K | -30.95M | -108.00K | -1.00 |
| Income Before Tax | -25.55M | 94.83M | 92.65M | -5.53M | -30.00M | -8.08M | 63.11M | 78.88M | 80.31M | 61.55M | 51.20M | 21.86M | 32.81M |
| Income Before Tax Ratio | -2.83% | 8.59% | 7.78% | -0.61% | -4.31% | -1.01% | 7.05% | 7.82% | 9.92% | 8.54% | 8.41% | 4.74% | 7.66% |
| Income Tax Expense | -7.67M | 28.01M | 28.44M | 847.00K | -6.34M | -1.85M | 18.17M | 28.58M | 28.05M | 21.75M | 18.40M | 7.42M | 11.12M |
| Net Income | -17.89M | 66.82M | 64.21M | -6.38M | -49.64M | -6.92M | 44.94M | 50.30M | 52.25M | 39.80M | 32.80M | 14.44M | 21.69M |
| Net Income Ratio | -1.98% | 6.05% | 5.39% | -0.71% | -7.14% | -0.86% | 5.02% | 4.99% | 6.46% | 5.52% | 5.39% | 3.13% | 5.06% |
| EPS | -1.74 | 6.52 | 6.26 | -0.62 | -4.84 | -0.67 | 4.38 | 4.91 | 5.10 | 3.88 | 3.20 | 1.41 | 2.11 |
| EPS Diluted | -1.74 | 6.52 | 6.26 | -0.62 | -4.84 | -0.67 | 4.38 | 4.91 | 5.10 | 3.88 | 3.20 | 1.41 | 2.11 |
| Weighted Avg Shares Out | 10.28M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M |
| Weighted Avg Shares Out (Dil) | 10.28M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M | 10.25M |
Source: https://incomestatements.info
Category: Stock Reports